CompletedNot Applicable

AVL200 IOL for Treatment of Cataract and Presbyopia

India9 participantsStarted 2022-07-25

Plain-language summary

This study is to evaluate the performance of the AVL200 IOL in terms of visual function improvement over a range of focal points. Participants meeting eligibility criteria will undergo cataract surgery with implantation of the AVL200 intraocular lens (IOL), then be followed through 1 year postoperatively. Postoperative assessments include safety and visual function.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Visually significant cataract * Best corrected distance visual acuity between 20/40 and 20/200 * Potential distance visual acuity of 20/32 or better * Corneal astigmatism ≤ 1.5 diopters Exclusion Criteria: * Use of medication that could affect accommodation * Previous corneal surgery or significant corneal abnormalities * Ocular pathology or degenerative disorder having potential to impair visual acuity * Pupil abnormality * Intraoperative cataract surgery complications that could affect IOL implantation or positioning

What they're measuring

Change in monocular best corrected distance visual acuity

Timeframe: 3 months postoperative

Trial details

NCT IDNCT05627700

SponsorAtia Vision

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-12-30

View on ClinicalTrials.gov More Cataract trials